Skip to content

Transpara 1.3.y

by Screenpoint Medical B.V.

Transpara 1.3.y is a X-ray image interpretive software (FDA Class II; FDA product code QDQ) made by Screenpoint Medical B.V., cleared under FDA 510(k) K181704 on 21 Nov 2018 and listed in FDA GUDID since 4 Feb 2019 (UDI-DI 08719326450100), active as of 23 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 23 Oct 2026

Documents

510(k) K181704

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number08719326450100 UDI-DI Date4 Feb 2019ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK181704 Date21 Nov 2018DecidedStatusActive

Official records

From the FDA record

Device description
The ScreenPoint Transpara system is intended for use as a concurrent reading aid for physicians interpreting screening mammograms, to identify regions suspicious for breast cancer and assess their likelihood of malignancy. Output of the device includes marks placed on suspicious soft tissue lesions and suspicious calcifications; region‐based scores, displayed upon the physician’s query, indicating the likelihood that cancer is present in specific regions; and an overall score indicating the likelihood that cancer is present on the mammogram. Patient management decisions should not be made solely on the basis of analysis by Transpara.
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Across registries

2 registries list this device

  • FDA 510(k) K181704 decided 21 Nov 2018 Active
  • FDA GUDID UDI-DI 08719326450100 listed 4 Feb 2019 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K181704
  2. Listed FDA GUDID 08719326450100

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Transpara
Generic name
X-ray image interpretive software
Model / reference
1.3.y
Primary DI / UDI-DI
08719326450100
510(k) Number
FDA product code
QDQ
GMDN term
X-ray image interpretive software
Device class
Class II
Regulation number
892.2090
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code QDQ (Radiological Computer Assisted Detection/Diagnosis Software For Lesions Suspicious For Cancer).

Other devices from Screenpoint Medical B.V.

See all devices from Screenpoint Medical B.V. →

Properties

  • Lot / batch number
  • Serial number
Other properties (13, all answered No)